These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35818663)

  • 1. Parenteral and Oral Anticoagulant Treatment for Hospitalized and Post-Discharge COVID-19 Patients: A Systematic Review and Meta-Analysis.
    Tunjungputri RN; Tetrasiwi EN; Mulansari NA; Harimurti K; Nelwan EJ
    Acta Med Indones; 2022 Apr; 54(2):190-209. PubMed ID: 35818663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different Anticoagulant Regimens, Mortality, and Bleeding in Hospitalized Patients with COVID-19: A Systematic Review and an Updated Meta-Analysis.
    Parisi R; Costanzo S; Di Castelnuovo A; de Gaetano G; Donati MB; Iacoviello L
    Semin Thromb Hemost; 2021 Jun; 47(4):372-391. PubMed ID: 33851386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboprophylaxis in Patients with COVID-19: Systematic Review of National and International Clinical Guidance Reports.
    Kyriakoulis KG; Kollias A; Kyriakoulis IG; Kyprianou IA; Papachrysostomou C; Makaronis P; Kotronias RA; Terentes-Printzios D; Toskas I; Mikhailidis DP
    Curr Vasc Pharmacol; 2022; 20(1):96-110. PubMed ID: 34431465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of anticoagulants in patients with COVID-19: a living systematic review and meta-analysis.
    Batista DR; Floriano I; Silvinato A; Bacha HA; Barbosa AN; Tanni SE; Bernardo WM
    J Bras Pneumol; 2022; 48(4):e20220041. PubMed ID: 35674523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.
    Kahn SR; Morrison DR; Diendéré G; Piché A; Filion KB; Klil-Drori AJ; Douketis JD; Emed J; Roussin A; Tagalakis V; Morris M; Geerts W
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD008201. PubMed ID: 29687454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of anticoagulation in lowering the mortality in hospitalized covid-19 patients: Meta-analysis of available literature.
    Aamir Waheed M; Rashid K; Rajab T; Rajab A; Adnan AH; Fayyaz H; Ibad AA; Basri R; Khan Y; Alhabib HI; Elzouki A
    Saudi Med J; 2022 Jun; 43(6):541-550. PubMed ID: 35675936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population.
    Mahan CE; Fisher MD; Mills RM; Fields LE; Stephenson JJ; Fu AC; Spyropoulos AC
    Thromb Res; 2013 Nov; 132(5):520-6. PubMed ID: 24080150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eligibility for Posthospitalization Venous Thromboembolism Prophylaxis in Hospitalized Patients With COVID-19: A Retrospective Cohort Study.
    Vaughn VM; Ratz D; McLaughlin ES; Horowitz JK; Flanders SA; Middleton EA; Grant PJ; Kaatz S; Barnes GD
    J Am Heart Assoc; 2022 Oct; 11(19):e025914. PubMed ID: 36073649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration.
    Tritschler T; Mathieu ME; Skeith L; Rodger M; Middeldorp S; Brighton T; Sandset PM; Kahn SR; Angus DC; Blondon M; Bonten MJ; Cattaneo M; Cushman M; Derde LPG; DeSancho MT; Diehl JL; Goligher E; Jilma B; Jüni P; Lawler PR; Marietta M; Marshall JC; McArthur C; Miranda CH; Mirault T; Morici N; Perepu U; Schörgenhofer C; Sholzberg M; Spyropoulos AC; Webb SA; Zarychanski R; Zuily S; Le Gal G;
    J Thromb Haemost; 2020 Nov; 18(11):2958-2967. PubMed ID: 32888372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials.
    Ortega-Paz L; Galli M; Capodanno D; Franchi F; Rollini F; Bikdeli B; Mehran R; Montalescot G; Gibson CM; Lopes RD; Andreotti F; Angiolillo DJ
    Eur Heart J Cardiovasc Pharmacother; 2022 Sep; 8(7):677-686. PubMed ID: 34519777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation in COVID-19 patients - An updated systematic review and meta-analysis.
    Reis S; Popp M; Schießer S; Metzendorf MI; Kranke P; Meybohm P; Weibel S
    Thromb Res; 2022 Nov; 219():40-48. PubMed ID: 36113402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended post-discharge thromboprophylaxis in hospitalized COVID-19 patients.
    Spyropoulos AC
    Expert Rev Hematol; 2022 Jul; 15(7):597-605. PubMed ID: 35786377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic anticoagulants for people hospitalised with COVID-19.
    Flumignan RL; Tinôco JDS; Pascoal PI; Areias LL; Cossi MS; Fernandes MI; Costa IK; Souza L; Matar CF; Tendal B; Trevisani VF; Atallah ÁN; Nakano LC
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013739. PubMed ID: 33502773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
    Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
    Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients: a meta-analysis of multicenter randomized controlled trials.
    Pilia E; Belletti A; Fresilli S; Finco G; Landoni G
    J Thromb Thrombolysis; 2022 Oct; 54(3):420-430. PubMed ID: 35922578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic Thromboprophylaxis and Thrombosis in Hospitalized Patients with COVID-19: A Pooled Analysis.
    Patell R; Chiasakul T; Bauer E; Zwicker JI
    Thromb Haemost; 2021 Jan; 121(1):76-85. PubMed ID: 33378787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis.
    Zhang S; Li Y; Liu G; Su B
    Thromb J; 2021 Nov; 19(1):91. PubMed ID: 34819094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19.
    Vaughn VM; Yost M; Abshire C; Flanders SA; Paje D; Grant P; Kaatz S; Kim T; Barnes GD
    JAMA Netw Open; 2021 Jun; 4(6):e2111788. PubMed ID: 34115129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation outcomes in hospitalized Covid-19 patients: A systematic review and meta-analysis of case-control and cohort studies.
    Kamel AM; Sobhy M; Magdy N; Sabry N; Farid S
    Rev Med Virol; 2021 May; 31(3):e2180. PubMed ID: 33022834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.